Professor Dame Kay Davies

Professor Dame Kay Davies was appointed as a Non-Executive Director of Oxford Biomedica in March 2021. Professor Davies is a world-leading human geneticist with a research focus on the molecular analysis of neuromuscular and neurological disease. She is currently Professor of Genetics and Co-Director of MDUK Oxford Neuromuscular Centre at the University of Oxford. She was co-founder of Summit Therapeutics plc, a spinout from her research activities. She also sits on the Board of UCB S.A. and The Biotech Growth Trust plc and was appointed a governor of the Wellcome Trust in 2008, serving as Deputy Chairman between 2013 and 2017. Professor Davies has a BA in Chemistry and a DPhil in Biochemistry from the University of Oxford.

Committee membership

• Remuneration Committee
• Nomination Committee